Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Trial of ALTO-207 in Adults With Treatment-resistant Depression

NCT07553637 is registered in ClinicalTrials.gov with Alto Neuroscience as lead sponsor.

NCT NCT07553637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07553637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Trial of ALTO-207 in Adults With Treatment-resistant Depression
Lead sponsor
Alto Neuroscience
Phase
Phase 2
Overall status
Recruiting
Start date
May 31, 2026
Completion date
December 31, 2027
Enrollment
178 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant depression (trd)